Literature DB >> 6207242

Cryptic epitope explains the failure of a monoclonal antibody to bind to certain isolates of Trypanosoma cruzi.

L V Kirchhoff, S Hieny, G M Shiver, D Snary, A Sher.   

Abstract

A mouse monoclonal antibody, WIC 29.26 Ab, has previously been characterized as recognizing a carbohydrate epitope on a 72,000 m.w. glycoprotein (GP72) expressed on the surface of Trypanosoma cruzi epimastigotes and metacyclic trypomastigotes. This molecule has been implicated as a receptor in the control of parasite transformation, and when used as an immunogen in mice, partially protects against T. cruzi infection. In previous experiments in which a radioimmunoassay was used, WIC 29.26 Ab was found to react with approximately 50% of T. cruzi strains and clones derived from a variety of sources. In this study, we attempted to determine whether the WIC 29.26 Ab-nonreactive isolates lack the entire GP72 or merely lack the epitope recognized by this monoclonal antibody. WIC 226.4 Ab, a monoclonal antibody raised against periodate-treated GP72, reacted in an immunofluorescence assay with all strains and clones studied, including those which had not reacted with WIC 29.26 Ab. Likewise, two polyvalent rabbit sera, directed specifically against GP72, bound to all T. cruzi isolates tested. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of detergent lysates of surface-labeled epimastigotes immunoprecipitated with WIC 29.26 Ab showed that the epitope bound by this antibody was present in all but one of the parasites that were surface-nonreactive, as well as in all those that were surface-reactive. WIC 29.26 Ab precipitated a single 72K Mr band from most strains and clones, but in several cases 79K Mr and 66K Mr bands were seen. Isolates from both the surface-reactive and the surface-nonreactive groups showed the latter pattern. These results demonstrate that GP72, or similar electrophoretic variants--and with one exception, the carbohydrate epitope bound by WIC 29.26 Ab--are present in the surface membrane of all strains and clones tested. This observation suggests that in intact epimastigotes of the surface-nonreactive isolates, the epitope is not accessible because of structural changes in the molecule itself or because of differences in the membrane environment of GP72.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6207242

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges.

Authors:  D F Hoft; C S Eickhoff
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

2.  Prevalence of antibodies to 72-kilodalton glycoprotein (GP72) in patients with Chagas' disease and further evidence of zymodeme-associated expression of GP72 carbohydrate epitopes.

Authors:  M Schechter; A F Stevens; A O Luquetti; D Snary; A K Allen; M A Miles
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

3.  Stable transfection of Trypanosoma cruzi epimastigotes with the trypomastigote-specific complement regulatory protein cDNA confers complement resistance.

Authors:  K A Norris
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Detection of Trypanosoma cruzi by DNA amplification using the polymerase chain reaction.

Authors:  D R Moser; L V Kirchhoff; J E Donelson
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

5.  Molecular cloning and characterization of the 78-kilodalton glucose-regulated protein of Trypanosoma cruzi.

Authors:  R S Tibbetts; I Y Kim; C L Olson; L M Barthel; M A Sullivan; A G Winquist; S D Miller; D M Engman
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  Utility of recombinant flagellar calcium-binding protein for serodiagnosis of Trypanosoma cruzi infection.

Authors:  L M Godsel; R S Tibbetts; C L Olson; B M Chaudoir; D M Engman
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

7.  Trypanosoma cruzi GP63 proteins undergo stage-specific differential posttranslational modification and are important for host cell infection.

Authors:  Manjusha M Kulkarni; Cheryl L Olson; David M Engman; Bradford S McGwire
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

8.  Serodiagnosis of Chagas' disease using monoclonal antibody against Trypanosoma cruzi-specific Mr 25,000 antigen.

Authors:  H Tachibana; K Nagakura; Y Kaneda
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

9.  A monoclonal antibody for distinction of invasive and noninvasive clinical isolates of Entamoeba histolytica.

Authors:  A Gonzalez-Ruiz; R Haque; T Rehman; A Aguirre; C Jaramillo; G Castañon; A Hall; F Guhl; G Ruiz-Palacios; D C Warhurst
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

10.  Bioluminescent imaging of Trypanosoma cruzi infection.

Authors:  Kenneth V Hyland; Sofya H Asfaw; Cheryl L Olson; Melvin D Daniels; David M Engman
Journal:  Int J Parasitol       Date:  2008-04-25       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.